53I · (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1R)-1-(2-methylprop-1-en-1-yl)phthalazin-2(1H)-y l]prop-2-en-1-one

Binding sites

53I in 2 structures; the first of them:

• 4ELH · Structure-activity relationship guides enantiomeric preference among potent inhibitors of… · 53I A202 · binds MET6, VAL7, ALA8, ILE15, ASN19, ASN20, LEU21, GLU28 and 13 more
• 4ELH · Structure-activity relationship guides enantiomeric preference among potent inhibitors of… · 53I A202 · binds MET6, VAL7, ALA8, ILE15, ASN19, ASN20, LEU21, GLU28 and 13 more

Residues it binds most

LEU 16, ASN 16, ALA 16, VAL 16, ILE 16, ARG 16, GLN 16, GLU 16, LYS 16, MET 16 (residue and the binding sites it lines).

Found with

• 53J · (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(2-methylprop-1-en-1-yl)phthalazin-2(1H)-y l]prop-2-en-1-one
• CA · Calcium ion
• CL · Chloride ion